KFDA to review possible approval of new chemical drugs with novel salts

Published: 2004-11-18 06:57:00

Updated: 2004-11-18 06:57:00

The Korea Food and Drug Administration said recently it is now considering allowing the approval of new chemical drugs with novel salts in re-examination period after consultation with legal advisors, saying that newly formulated drugs with novel salts prove to be different from original drugs in...

Fees

- Email service daily and homepage access.

$300 per month. ($3,240 per year)
5 Email holders per each company.
Anual contract base.

Latest News

Which are outstanding tetravalent vaccines even for the young?

Disease treated the most with clinical trial drugs is respiratory disorder like lung cancer

Who will be the next Pharmaceutical Safety Bureau Director?

Celltrion completes clinical trials for Remsima SC for European approval

Sales listed pharmas made in the first half of the year

TOP

BACK